Abstract
Plasma ACE2 activity is persistently elevated in patients after COVID-19 infection. Larger studies are needed to determine if this identifies people at risk of prolonged illness following COVID-19.
Patel SK, Juno JA, Lee WS, Wragg KM, Hogarth PM, Kent SJ, Burrell LM
VIEW FULL ARTICLEJournal The European Respiratory Journal
Published 13 May 2021
Volume 57
ISSUE 5
Pagination 2003730
DOI https://doi.org/10.1183/13993003.03730-2020
Plasma ACE2 activity is persistently elevated in patients after COVID-19 infection. Larger studies are needed to determine if this identifies people at risk of prolonged illness following COVID-19.